Is Black Diamond Therapeutics Inc (BDTX) overvalued? · $95.7M cap
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
This page asks whether Black Diamond Therapeutics Inc (BDTX) looks expensive on cached numbers — not a short thesis.
No cached income statement for BDTX, so there is no earnings base to call rich or cheap.
BDTX currently screens at market cap $95.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BDTX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BDTX stock page for the full model, not this heading.
Not investment advice.